In 1979, Stanley Olsztyn
M.D. came to the conclusion that standard medical treatments
in many cases were failing his patients. Antibiotics, which were supposed
to be the miracle cure of a generation, often proved ineffective, costly,
and worse, left behind a new series of health problems. Dr. Olsztyn's frustration
turned to concern when health problems struck closer to home. His wife
contracted a serious staphylococcal sinus infection while caring for burn
patients, and his infant son suffered from recurring ear and throat infections.
The antibiotics prescribed only compounded their fatigue and misery, and
their bodies developed resistance to the antibiotics through overuse. In
his tireless search for alternative methods, Dr. Olsztyn realized that
the problem and solution lay at the source: the body's immune system. He
felt that the only way to combat immune deficiencies was to help the human
body help itself. With the support and assistance of numerous colleagues,
Dr. Olsztyn made the revolutionary immunomodulator discovery that eventually
led to the formulation of Matol BIOMUNE
OSF PlusTM. |
 Dr.
Jesse Stoff, a colleague of Dr. Olsztyn, is a nationally
known author, lecturer and clinical researcher in viro-immunology and a
recognized authority on chronic fatigue syndrome. In addition to serving
as the Medical Director of IntegraMed in Tucson, Arizona, Dr. Stoff is
also the Medical Director of the Stoff Institute for Medical Research;
a non-profit corporation dedicated to the development of new therapeutic
strategies for treating viro-immunological diseases. Over a 3 year period,
Dr. Stoff conducted extensive clinical and laboratory testing on the effects
of Dr. Olsztyn's discovery. Through his findings, Dr. Stoff was able to
transform Stanley Olsztyn's amazing breakthrough into a product that would
change people's lives. The outstanding results have been published in The
Matol Biomune OSF Plus-Report, which focuses on the changes
in natural killer (NK) cell activity in selected patients who received
Matol
BIOMUNE OSF PlusTM." |